In the BioHarmony Drug Report Database
Edotreotide
Ga-68-DOTATOC, SomaKit TOC (edotreotide) is a small molecule pharmaceutical. Edotreotide was first approved as Ga-68-DOTATOC on 2016-12-08. It has been approved in Europe to treat neuroendocrine tumors and radionuclide imaging. It is known to target somatostatin receptor type 2.
Trade Name
|
SomaKit TOC |
|---|---|
Common Name
|
edotreotide |
ChEMBL ID
|
CHEMBL408350 |
Indication
|
neuroendocrine tumors, radionuclide imaging |
Drug Class
|
Peptides: inhibition of growth hormone release |
Image (chem structure or protein)